1-adamantylmethyl 5-[hydroxy(tetrahydrofuran-2-yl)amino]isoxazole-3-carboxylate

ID: ALA3746662

PubChem CID: 102336052

Max Phase: Preclinical

Molecular Formula: C19H26N2O5

Molecular Weight: 362.43

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(OCC12CC3CC(CC(C3)C1)C2)c1cc(N(O)C2CCCO2)on1

Standard InChI:  InChI=1S/C19H26N2O5/c22-18(15-7-17(26-20-15)21(23)16-2-1-3-24-16)25-11-19-8-12-4-13(9-19)6-14(5-12)10-19/h7,12-14,16,23H,1-6,8-11H2

Standard InChI Key:  ATRRNMVKSDCRIY-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 26 30  0  0  0  0  0  0  0  0999 V2000
    3.7345    1.5436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7345    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8300    2.8133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5893   -0.5726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5602    2.2656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5602    0.5726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1246    2.2656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1246    0.5726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2034   -0.5726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0291    0.0249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1839    1.1572    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9852    0.2541    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5953   -0.0633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0132    0.3857    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8712   -0.8447    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9661   -2.0409    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5488   -1.5498    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3691   -0.8769    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9909    0.1494    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0923   -2.1920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5696   -2.3637    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8478   -3.8377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5319   -4.5578    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4404   -3.5288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3966    0.8398    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5431    2.0308    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  2  4  1  0
  3  5  1  0
  4  6  1  0
  5  6  1  0
  7  8  1  0
  3  7  1  0
  2  9  1  0
  6 10  1  0
 10  8  1  0
  8  9  1  0
  6 11  1  0
 11 12  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 13  2  0
 15 18  1  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 20  1  0
 13 25  1  0
 25 26  2  0
 25 12  1  0
M  END

Associated Targets(Human)

SH-SY5Y (11521 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

LOX1.1 Seed lipoxygenase-1 (463 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Brain (4256 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 362.43Molecular Weight (Monoisotopic): 362.1842AlogP: 3.38#Rotatable Bonds: 5
Polar Surface Area: 85.03Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 13.31CX Basic pKa: CX LogP: 3.23CX LogD: 3.43
Aromatic Rings: 1Heavy Atoms: 26QED Weighted: 0.63Np Likeness Score: -0.38

References

1. Averina EB, Vasilenko DA, Gracheva YA, Grishin YK, Radchenko EV, Burmistrov VV, Butov GM, Neganova ME, Serkova TP, Redkozubova OM, Shevtsova EF, Milaeva ER, Kuznetsova TS, Zefirov NS..  (2016)  Synthesis and biological evaluation of novel 5-hydroxylaminoisoxazole derivatives as lipoxygenase inhibitors and metabolism enhancing agents.,  24  (4): [PMID:26753816] [10.1016/j.bmc.2015.12.040]

Source